Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |